Wai Yuen Tong Medicine held annual shareholder meeting, resolutions passed in poll vote

• Wai Yuen Tong Medicine Holdings held its annual general meeting on Aug. 19, 2026.
• Shareholders adopted the audited consolidated financial statements and related directors’ and auditor’s reports for the year ended March 31, 2026.
• Ernst & Young was reappointed as auditor, with authority granted to set its remuneration.
• Directors received fresh general mandates to issue securities, repurchase shares, and extend the issuance mandate by shares repurchased.
• A special resolution authorizing the proposed share premium reduction was passed; execution remains subject to the stated condition being fulfilled.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wai Yuen Tong Medicine Holdings Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260819-12290193), on August 19, 2026, and is solely responsible for the information contained therein.